Riemser Arzneimittel AG [HIST] - Resultados da pesquisa

União Europeia - português - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - agentes antineoplásicos - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

bluxam 20 mg/ml suspensão injetável

riemser pharma gmbh - triamcinolona - suspensão injetável - 20 mg/ml - triamcinolona, hexacetonido 20 mg/ml - triamcinolone - n/a - duração do tratamento: longa duração

Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

ostac 520 mg comprimido revestido

esteve pharmaceuticals gmbh - Ácido clodrónico - comprimido revestido - 520 mg - clodronato dissódico tetra-hidratado 649.73 mg - clodronic acid - n/a - duração do tratamento: longa duração

Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

ostac 520 mg comprimido revestido

União Europeia - português - EMA (European Medicines Agency)

kinpeygo

stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarreicos, intestinal antiinflamatórios / anti infeccioso agentes - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.